Clinical Trials Browser

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT07590648 2026-05-15

E-STOP2

Phase 4 Not yet recruiting

136 enrolled

Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT07528417 2026-04-22

MYELO-CAN:ABX

Phase 2 Not yet recruiting

75 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT05537896 2026-04-16

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

Phase 2 Recruiting

55 enrolled

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

NCT06056908 2026-04-06

SDSR

Recruiting

5,000 enrolled

Classical hematologyOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Shwachman-Diamond Syndrome, Leukemia, Neutropenia

NCT07300735 2025-12-29

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

Phase NA Recruiting

88 enrolled

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

NCT01916057 2025-09-08

CANHPARI

Phase NA Completed

100 enrolled

Other hematologic neoplasm

Invasive Fungal Infections, Neutropenia, Hematologic Neoplasms, Genetic Predisposition to Disease, Immune Reconstitution Inflammatory Syndrome

NCT07047352 2025-07-02

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)

Phase NA Not yet recruiting

91 enrolled

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

Clinical Trials

Screening for Hematology Branch Protocols

E-STOP2

MYELO-CAN:ABX

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

SDSR

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

CANHPARI

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)